ACE2 and COVID-19: The goal of this study is to see if there is a link between illness risk, etiology, clinical-laboratory characteristics, lung involvement development, and the ACE2 G8790A and AT2R A1675G gene polymorphisms in people with COVID-19 who are newly diagnosed, untreated, and without a history of autoimmune disease in the Turkish population.